Peer-reviewed Publications 2025

  1. Viremia Does Not Independently Predict Cardiovascular Disease in People With HIV: A RESPOND Cohort Study Elvstam O, Ryom L, Neesgaard B, Tau L, Günthard HF, Zangerle R, Vehreschild JJ, Wit F, Sönnerborg A, Kovari H, Abutidze A, Petoumenos K, Jaschinski N, Hosein S, Bogner J, Grabmeier-Pfistershammer K, Garges H, Rooney J, Young L, Law M, Kirk O; RESPOND Study Group.
    Open Forum Infect Dis. 2025 Jan;12(2):ofaf016.  Abstract

  2. A simple tool to evaluate the effectiveness of HIV care for settings with gaps in data availability (ESTIHIV) Raben D, Jakobsen ML, Trajanovska J, Kowalska J, Vassilenko A, Dragas S, Harxhi A, Dragovic G, Jaschinski NJ, Neesgaard B, Hjorth-Larsen K, Garges H, Gallant J, Lundgren JD, Philips A, Cambiano V, Yazdanpanah Y, Mocroft A.
    PLoS One. 2025 Jan;20(1):e0316794.  Abstract

  3. Risk of cancer in people with HIV experiencing varying degrees of immune recovery with sustained virological suppression on antiretroviral treatment for more than 2 years: an international, multicentre, observational cohort. Han WM, Ryom L, Sabin CA, Greenberg L, Cavassini M, Egle A, Duvivier C, Wit F, Mussini C, d'Arminio Monforte A, Castagna A, Miro JM, van der Valk M, Bonnet F, Pradier C, Skocic M, Matulionyte R, Stöckle M, Jaschinski N, Timiryasova A, Tallada J, Rogatto FP, Vannappagari V, Young LA, Lundgren JD, Petoumenos K, Hoy JF.
    Clin Infect Dis. 2025 May:ciaf248. Epub ahead of print.   Abstract

  4. Incident tuberculosis in people with HIV across Europe from 2012 to 2022: incidence rates, risk factors and regional differences in a multicentre cohort study.  Kraef C, Roen A, Podlekareva D, Bakowska E, Nemeth J, Knappik M, Payen MC, Wit F, Mussini C, d'Arminio Monforte A, Castagna A, Chkhartishvili N, Neesgaard B, Jaschinski N, Anne AV, Borodulina E, Ballif M, Wallner E, Israelski D, Garges H, Mocroft A, Kirk O; RESPOND Study Group.
    Eur Respir J. 2025 Jun;65(6):2401904.   Abstract

  5. Mortality using raltegravir versus other integrase strand-transfer inhibitors in people with HIV in Europe and Australia: a prospective multicentre study Tusch E, Ryom L, Hoffmann C, Degen O, Zangerle R, Günthard HF, Wit F, Mussini C, Castagna A, Martin C, Giacomelli A, Vehreschild JJ, Begovac J, Vannappagari V, Rooney J, Mendes SDS, Tallada J, Kowalska J, Wallner E, Kusejko K, Naschinski N, Lundgren J, Peters L, Reekie J
    eClinicalMedicine 2025  Abstract

  6. SARS-Cov-2 vaccination strategies in hospitalized recovered COVID-19 patients: a randomized clinical trial (VATICO Trial). Sábato S, Benet S, Rogers AJ, Murray TA, Skeans M, Mothe B, Paredes R, Mourad A, Kiweewa F, Kamel D, Jain MK, Lutaakome J, Nalubega MG, Sebudde N, Mylonakis E, Braun DL, Hatlen T, Kimuli I, Kitko C, Mugerwa H, Kitonsa J, Kim K, Tien PC, Highbarger J, McCormack AL, Sanchez A, Murray DD, Babiker AG, Davey VJ, Files DC, Gelijns AC, Higgs ES, Kan VL, Matthews GV, Pett SL, Lane HC, Reilly C, Goodman AL, Lundgren JD, Moltó J; ACTIV-3/VATICO study group and the STRIVE Network.
    Sci Rep. 2025;15(1):9882.  Abstract

  7. Genetics in a Danish Common Variable Immunodeficiency Cohort. Drabe CH, Laustsen MM, Marquart HV, Hartling HJ, Marvig RL, Helweg-Larsen J, Hansen AE, Lundgren J, Helleberg M, Borgwardt L, Katzenstein TL.
    J Clin Immunol. 2025;45(1):102.  Abstract

  8. Long-term outcomes of passive immunotherapy for COVID-19: a pooled analysis of a large multinational platform randomized clinical trial. Mourad A, Grandits GA, Siegel LK, Engen N, Barkauskas C, Eriobu N, Jain MK, Jensen TO, Ginde A, Higgs E, Knox DB, Kitonsa J, Kim K, Malin JJ, Rapti V, Price DA, Mena Lora AJ, Mathews G, Mylonakis E, Murray TA, Sandkovsky U, Paredes R, Ramachandruni S, Reilly C, Vock D, Williamson JC, Young BE, Self WH, Lundgren J, Holland TL; INSIGHT ACTIV-3/TICO Study Group and the STRIVE Network.
    Clin Microbiol Infect. 2025;31(6):1053-1060.  Abstract

  9. Functional immune reconstitution after allogeneic hematopoietic stem cell transplantation in myeloablative and non-myeloablative conditioned patients. Brooks PT, Minculescu L, Svanberg Teglgaard R, Hartling HJ, Salado-Jimena JA, Friis LS, Kornblit B, Schjødt I, Petersen SL, Andersen NS, Nielsen SD, Lundgren J, Marquart HV, Gjaerde LK, Sengeløv H, Ostrowski SR.
    Sci Rep. 2025;15(1):21029  Abstract

  10. Immunogenicity and Safety of the COVID-19 mRNA Vaccine Coadministered with Influenza and 23-valent Pneumococcal Polysaccharide Vaccines. Rezahosseini O, Stæhr Jensen JU, Rahimi HK, Jensen NE, Jørgensen CS, Fischer TK, Ostrowski SR, Lundgren J, Ostergaard L, Harboe ZB.
    Clin Infect Dis. 2025:ciaf455. Epub ahead of print.  Abstract

  11. The diagnostic value of soluble Epstein-Barr Virus BZLF1 protein (sZEBRA) in the Detection of Post-transplant lymphoproliferative Disease (PTLD) among Solid Organ (SOT) and Haematopoietic Cell (HSCT) Transplant Recipients. Wareham NE, Kjærgaard VS, Habib M, Reekie J, Rossing K, Sengeløv H, Buisson M, Lenormand JL, Perch M, Schultz N, Kirkby N, Sørensen SS, Lupo J, Lundgren JD, Murray DD, Drouet E.
    J Infect Dis. 2025 Sep:jiaf477. Epub ahead of print.  Abstract

  12. Evaluation of antiretroviral regimen switching options in adults with HIV with sustained viral load non-suppression on dolutegravir, lamivudine, and tenofovir in eastern, central, southern, and western Africa: a modelling study. Phillips AN, Bansi-Matharu L, van Oosterhout JJ, Hyle E, van de Vijver D, Kouyos R, Hong SY, Chun H, Raizes E, Kantor R, Jordan MR, Vitoria M, Ford N, Mugurungi O, Apollo T, Chimberengwa P, Meintjes G, Siedner M, Lundgren J, Schapiro J, Flexner C, Loosli T, Cambiano V, Smith J, Xia R, McCluskey S, Mewoabi S, Calmy A, Eholie SP, Revill P.
    Lancet HIV. 2025;12(8):e578-e586.  Abstract

  13. Adenovirus Infections and Disease in Solid Organ Transplant Recipients: Incidence and Outcomes. Grarup KR, Schwartz Sørensen S, Perch M, Schultz N, Gustafsson F, Brix Christensen V, Schønning K, Sommerlund Moestrup K, Lundgren J, Crone CG, Helleberg M.
    Open Forum Infect Dis. 2025;12(2):ofaf032.  Abstract

  14. Use of Preventive Measures for Cardiovascular Disease in People With HIV. Jaschinski N, Neesgaard B, Wit F, Van der Valk M, Kowalska J, Ridolfo AL, Günthard HF, Stöckle M, Wallner E, Nowak P, Castagna A, d'Arminio Monforte A, Petoumenos K, Hoy JF, Hosein S, Lundgren J, Garges H, Rogatto F, Young L, Peters L, Mocroft A, Ryom L; RESPOND Study Group.
    Open Forum Infect Dis. 2025;12(10):ofaf586.  Abstract

  15. Blood absolute lymphocyte count and trajectory are important in understanding severe COVID-19. Paules CI, Nordwall JA, Shaw-Saliba K, Aberg JA, Gardner EM, Goodman AL, Kumarasamy N, Vasudeva S, Vock DM, North CM, Lundgren J, Aggarwal NR; STRIVE Network and TICO Trial Study Group.
    BMC Infect Dis. 2025;25(1):67.  Abstract

  16. Possible scenarios for the spread of mpox outside the endemic focus in Africa. Petersen E, Hvid U, Tomori O, Pedersen AG, Wallinga J, Pebody R, Cenciarelli O, Aavitsland P, Van Laeken D, Andreasen V, Schneider U, Simonsen JK, Goedknegt MJF, Johannesen CK, Lundgren JD, Koch A, Søborg B, Ekström AM, Nohynek H, Aarestrup FM, Krause TG, Simonsen L.
    Int J Infect Dis. 2025;153:107373.  Abstract

  17. The Gut Microbiome and Its Resistome as Predictors of Clinical Infections and Phenotypic Antibiotic Resistance in Hematopoietic Stem Cell Transplant Recipients. Nørgaard JC, Marandi RZ, Ilett EE, Gulay A, Paredes R, Lundgren JD, Jørgensen M, Sengeløv H.
    J Infect Dis. 2025;232(4):806-814.  Abstract

  18. Associations Between Pre-Transplantation T Cell Populations and Acute Cellular Rejection Post-Liver Transplantation-Results From a Prospective Cohort Study. Scand J Immunol. Clemmesen JLR, Suarez-Zdunek MA, Møller DL, Hove-Skovsgaard M, Samuelsen S, Ostrowski SR, Willemoe GL, Pedersen CR, Lundgren J, Marquart HV, Hartling HJ, Rasmussen A, Nielsen SD.
    Scand J Immunol. 2025;102(2):e70048.  Abstract

  19. Evaluation of the Feasibility and Efficacy of Point-of-Care Antibody Tests for Biomarker-Guided Management of Coronavirus Disease 2019. Reilly C, Mylonakis E, Dewar R, Young B, Nordwall J, Bhagani S, Chia PY, Davis R, Files C, Ginde AA, Hatlen T, Helleberg M, Hayanga A, Jensen TO, Jain MK, Kalomenidis I, Kim K, Lallemand P, Lindegaard B, Menon A, Ognenovska K, Poulakou G, Thorup Røge B, Rogers AJ, Shaw-Saliba K, Sandkovsky U, Trautner BW, Vasudeva SS, Vekstein A, Viens K, Wyncoll J, DuChateau B, Zhang Z, Wu S, Babiker AG, Davey V, Gelijns A, Higgs E, Kan V, Lundgren J, Matthews GV, Lane HC.
    J Infect Dis. 2025;231(3):677-683.   Abstract

  20. Risk of severe bacterial infections including TB before and after immediate or deferred antiretroviral therapy: A multicenter, prospective, cohort study. Jensen TO, Sharma S, Avihingsanon A, Lutaakome J, Brar I, Burman W, Chetchotisakd P, de Castro N, Galán-Herrera JF, Kumarasamy N, Paredes R, Ridzon R, Sciaudone M, Singh K, Uriel A, Lundgren J, Reilly C, Matthews G.
    Int J Infect Dis. 2025;156:107911.  Abstract

  21. Post-tuberculosis lung disease patients benefit from vaccinations as other respiratory conditions. Migliori GB, Centis R, D'Ambrosio L, Visca D, Akkerman OW, Silva DR, Podlekareva D, Kherabi Y.
    Monaldi Arch Chest Dis. 2025. Epub ahead of print.  Abstract

  22. Multi-drug resistant tuberculosis: where should we be with optimal treatment? Pontali E, Centis R, D'Ambrosio L, Silva DR, Podlekareva D, Migliori GB.
    Expert Rev Anti Infect Ther. 2025;23(7):425-428.   Abstract

  23. Leukocyte count and new-onset diabetes mellitus in people with HIV: A longitudinal study.  Meyer SC, Klein Z, Schoepf IC, Thorball CW, Labarile M, Kootstra NA, Reiss P, Ryom L, Braun DL, Thurnheer MC, Marzolini C, Kahlert CR, Bernasconi E, Cavassini M, Marinosci A, Fellay J, Günthard HF, Kouyos RD, Ledergerber B, Tarr PE; Swiss HIV Cohort Study.
    HIV Med. 2025;26(10):1585-1599.   Abstract

  24. Low Trauma Fractures in People with HIV: Longitudinal Time Trends in the Swiss HIV Cohort Study 2009-2022.  Schoepf IC, Baltisberger V, Thorball CW, Ryom L, Wandeler G, Haerry D, Kahlert CR, Bernasconi E, Calmy A, Lamy O, Fellay J, Günthard HF, Ledergerber B, Tarr PE; Swiss HIV Cohort Study.
    Clin Infect Dis. 2025:ciaf392. Epub ahead of print  Abstract

  25. Statin use in HIV: European AIDS Clinical Society guidance for the primary prevention of cardiovascular disease. Alagaratnam J, van Bremen K, Behrens GMN, Boccara F, Cinque P, Gisslén M, Guaraldi G, Konopnicki D, Kowalska JD, Mallon PWG, Marzolini C, Mendão L, Miró JM, Negredo E, Reiss P, Ryom L, van der Valk M, Winston A, Nielsen SD, Martínez E.
    Lancet HIV. 2025;12(5):e382-e392.  Abstract

  26. The potential for annual long-acting HIV pre-exposure prophylaxis.  Ryom L.
    Lancet. 2025;405(10485):1120-1121.  Abstract

  27. Data Interoperability in COVID-19 Vaccine Trials: Methodological Approach in the VACCELERATE Project. Malik S, Dorothea ZP, Argyropoulos CD, Themistocleous S, Macken AJ, Valdenmaiier O, Scheckenbach F, Bardach E, Pfeiffer A, Loens K, Ochando JC, Cornely OA, Demotes-Mainard J, Contrino S, Felder G.
    JMIR Med Inform. 2025 Mar 7;13:e65590.  Abstract

  28. Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment. Munroe ES, Grandits GA, Hyzy RC, Prescott HC, Barrett TW, Dewar RL, Engen N, Goodman AL, Hatlen TJ, Highbarger H, Holland TL, Hughes G, Jensen TO, Khan MA, Kalomenidis I, Kang N, Laverdure S, Manian P, Menon V, Patel R, Ramachandruni S, Rehman T, Shaw-Saliba K, Røge BT, Vock DM, Weintrob AC, Young BE, Frosch AP; STRIVE Network and Therapeutics for Inpatients with COVID-19 (TICO) study groups.
    PLoS One. 2025;20(6):e0325561.  Abstract

  29. Mortality and Non-Fatal Clinical Outcomes After the Most Common Cancers in People with HIV: A Multicohort Collaboration. Timiryasova A, Greenberg L, Domingo P, Tarr PE, Egle A, Martin C, Mussini C, Wit F, Cingolani A, Lehmann C, Castagna A, Petoumenos K, Sabin CA, Bonnet F, Lundgren J, Bottanelli M, Hosein S, Carlander C, Amstutz A, Grabmeier-Pfistershammer K, Garges H, Marongiu A, Young LA, Peters L, Ryom L, On Behalf Of The D A D And Respond Study Groups.
    Cancers (Basel). 2025;17(24):4000.  Abstract

  30. Circulating HBV RNA and hepatitis B core-related antigen as determinants of HBsAg loss in persons with HIV in Europe. Begré L, Boyd A, Plissonnier ML, Testoni B, Béguelin C, Suter-Riniker F, Scholtès C, Rockstroh JK, Lacombe K, Peters L, Heil M, Levrero M, Rauch A, Zoulim F, Wandeler G; Swiss HIV Cohort Study, EuroSIDA and French HIV/HBV and Biliver cohorts; Members of the EuroSIDA Study Group; Members of the French HIV/HBV and Biliver cohorts.
    JHEP Rep. 2025;8(2):101671.   Abstract

  31. Antibiotic Consumption in Danish Intensive Care Units, 2013-2023: A Nationwide Study of Temporal Trends.  Meier NF, Hertz FB, Granholm A, Perner A, Sjövall F, Svan KB, Møller MH, Helleberg M.
    Acta Anaesthesiol Scand. 2025;69(9):e70124.  Abstract

  32. Explainable machine learning to identify chronic lymphocytic leukemia and medication use based on gut microbiome data.  Fait Kadlec T, Ilett EE, da Cunha-Bang C, Sengeløv H, Brieghel C, Gulay A, Rafiq S, Ravn HB, Zheng C, Nielsen RV, Sørensen SS, Zargari Marandi R, Niemann CU.
    Microbiol Spectr. 2025;13(12):e0094425.  Abstract

  33. Pre-departure PCR testing of travellers for SARS-CoV-2 was an effective tool in limiting transmission in Greenland during the early phases of the COVID-19 pandemic.  Møller M, Moestrup KS, Abelsen T, Vedsted P, Mølbak K, Koch A.
    BMC Public Health. 2025 Feb 12;25(1):585.  Abstract

  34. Prediction of bloodstream infection using machine learning based primarily on biochemical data. Marandi RZ, Hertz FB, Thomassen JQ, Rasmussen SC, Frikke-Schmidt R, Frimodt-Møller N, Nielsen KL, MacPherson CR.
    Sci Rep. 2025 May 20;15(1):17478.  Abstract

  35. Selective decontamination of the digestive tract in burn patients: A systematic review with meta-analysis.  Tsuchiya EA, Jensen-Abbew J, Krag M, Møller MH, Vestergaard MR, Haase N, Helleberg M, Holmgaard R, Heiberg J.
    Burns. 2025;51(5):107501.  Abstract

  36. Survival in Patients With Evidence of Pulmonary Thromboembolism on Ventilation-Perfusion SPECT 12 Weeks After Double Lung Transplantation: A Retrospective Cohort Study.  Mohammad M, Kristensen AW, Hartmann JP, Wareham NE, Buttar SN, Greve AM, Lund TK, Jensen K, Schultz HHL, Perch M, Berg RMG, Mortensen J.
    Clin Transplant. 2025 Feb;39(2):e70103.  Abstract

  37. The Empty Medicine Cabinet: Urgent Action Needed to Resolve TB Drug Shortages in Europe. Goletti D, Cirillo DM, Lange C, Tiberi S, Günther G, Petrone L, Kuksa L, Opota O, Akkerman O, Podlekareva D, Guglielmetti L, Duarte R.
    Int J Infect Dis. 2025 Oct;159:108022.  Abstract

  38. Use of selective decontamination of the digestive tract in burn patients: A European survey.  Tsuchiya EA, Krag M, Møller MH, Vestergaard MR, Haase N, Helleberg M, Holmgaard R, Heiberg J.
    Burns. 2026 Feb;52(1):107774. Epub ahead of print.  Abstract

  39. Vitamin D Deficiency at Hospital Admission With Community-Acquired Pneumonia is Associated With Increased Risk of Mortality: A Prospective Cohort Study.  Hegelund MH, Alam S, Dungu AM, Ryrsø CK, Faurholt-Jepsen D, Krogh-Madsen R, Jensen TO, Mølgaard C, Lindegaard B.
    Open Forum Infect Dis. 2025 Nov 19;12(12):ofaf706.  Abstract